- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Camrelizumab Fluzoparib
Total 484 results
-
Tianjin Medical University Cancer Institute and...RecruitingAdvanced HER2 Negative Breast Carcinoma | HRD+Breast CancerChina
-
wang shusenRecruitingAdvanced HER2 Negative Breast Carcinoma HRD+Breast CancerChina
-
Peking University People's HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Enrolling by invitationGermline BRCA-mutated HER2-negative Breast CancerChina
-
Fudan UniversityRecruitingNasopharyngeal Carcinoma | Nasopharyngeal CancerChina
-
Chongqing University Cancer HospitalNot yet recruitingPARP Inhibitor for Esophageal Squamous Cell Carcinoma
-
Ruijin HospitalRecruitingSarcoma | Sarcoma,Soft Tissue | Sarcoma of BoneChina
-
Jun GuoNot yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.UnknownAdvanced Pancreatic CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHealthy Adult SubjectsChina
-
Jiangsu HengRui Medicine Co., Ltd.307 Hospital of PLA; Peking University Cancer Hospital & InstituteCompletedAdvanced Solid MalignanciesChina
-
Ying LinRecruitingHer-2 Negative Breast Cancer | HRR Gene MutationChina
-
Atridia Pty Ltd.Completed
-
Atridia Pty Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSmall Cell Lung CancerChina
-
Shandong Provincial HospitalUnknown
-
Jiangsu HengRui Medicine Co., Ltd.UnknownSafety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Liver FunctionHealthy Subjects | Hepatic ImpairmentChina
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.; Peking University Shougang HospitalWithdrawnProgression | Pediatric Cancer | Effect of DrugsChina
-
Tongji HospitalFirst Affiliated Hospital Xi'an Jiaotong University; Wuhan Union Hospital,... and other collaboratorsRecruitingOvarian CancerChina
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | Non-small Cell Lung CancerChina
-
Peking Union Medical College HospitalCompletedApatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer (ACABC)Cholangiocarcinoma | Hepatobiliary Neoplasm | Biliary Tract Cancer | BiomarkerChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Enrolling by invitationAdvanced Solid TumorsChina
-
Zhejiang Cancer HospitalUnknown
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Qilu Hospital of Shandong UniversityJiangsu HengRui Medicine Co., Ltd.Not yet recruitingSmall Cell Lung Cancer
-
Xiaohua Wu MDNot yet recruitingRelapsed Ovarian Cancer
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Zhejiang Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingFemale Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
-
Zhejiang Cancer HospitalNot yet recruitingUterine Cervical Neoplasms | Oncolytic Virotherapy | CamrelizumabChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingTreatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA MutationChina
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingMetastatic Biliary Tract Cancer | Locally Advanced Biliary Tract CancerChina
-
Fujian Medical University Union HospitalRecruitingRadiotherapy | Immunotherapy | Esophageal NeoplasmChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Henan Provincial People's HospitalNot yet recruiting
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEndometrial Carcinoma | Recurrent or Metastatic | TP53 MutationChina
-
Guangxi Medical UniversityNot yet recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of OvaryChina
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Sun Yat-sen UniversityRecruitingParanasal Sinus Cancer | Induction Chemotherapy | Camrelizumab | Nasal Cavity Cancer | Intensity Modulated Radiotherapy | Concurrent ChemotherapyChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Peking UniversityNot yet recruiting
-
Hebei Medical University Fourth HospitalRecruiting
-
Nanfang Hospital of Southern Medical UniversityRecruitingNasopharyngeal Carcinoma | Oligometastasis | RadiotherapyChina
-
Fudan UniversityRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Beijing Jishuitan HospitalRecruitingSoft Tissue SarcomaChina
-
Huashan HospitalJiangsu HengRui Medicine Co., Ltd.; Shanghai Sunstem Biotechnology Co., Ltd.RecruitingRecurrent GlioblastomaChina
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingEsophageal Cancer by AJCC V8 StageChina